Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
Jonathan D. Roth(Rutgers, The State University of New Jersey), Henrik H. Hansen(Gubra (Denmark)), Romeo Papazyan(Johns Hopkins University), Luciano Adorini(Intercept Pharmaceuticals (United States)), Michael Feigh(Gubra (Denmark)), Kristoffer Rigbolt(University of Southern Denmark), Jacob Jelsing(Gubra (Denmark)), Niels Vrang(Gubra (Denmark)), Mark A. Young(Intercept Pharmaceuticals (United States)), Jens Christian Nielsen(Gubra (Denmark)), Sanne Skovgård Veidal(Gubra (Denmark)), Louise K. D. Fensholdt(Genesis HealthCare)
Cited by 53
Related Papers
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses
|Nature Neuroscience|2008|494
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
|Proceedings of the National Academy of Sciences|2008|433
Amylin: Pharmacology, Physiology, and Clinical Potential
|Pharmacological Reviews|2015|395